Alcon PE Ratio 2019-2025 | ALC
Current and historical p/e ratio for Alcon (ALC) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Alcon PE ratio as of June 13, 2025 is 28.73.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Alcon PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-06-13 | 86.20 | 38.31 | |
2025-03-31 | 94.59 | $2.25 | 42.04 |
2024-12-31 | 84.59 | $2.05 | 41.26 |
2024-09-30 | 99.71 | $2.34 | 42.61 |
2024-06-30 | 88.76 | $2.22 | 39.98 |
2024-03-31 | 82.72 | $2.11 | 39.20 |
2023-12-31 | 77.59 | $1.96 | 39.59 |
2023-09-30 | 76.53 | $0.90 | 85.04 |
2023-06-30 | 81.55 | $0.72 | 113.26 |
2023-03-31 | 69.84 | $0.68 | 102.70 |
2022-12-31 | 67.87 | $0.67 | 101.29 |
2022-09-30 | 57.60 | $1.15 | 50.09 |
2022-06-30 | 69.19 | $0.92 | 75.21 |
2022-03-31 | 78.31 | $0.93 | 84.21 |
2021-12-31 | 86.00 | $0.76 | 113.16 |
2021-09-30 | 79.44 | $0.67 | 118.56 |
2021-06-30 | 69.36 | $0.37 | 187.45 |
2021-03-31 | 69.09 | $-0.80 | 0.00 |
2020-12-31 | 64.95 | $-1.09 | 0.00 |
2020-09-30 | 56.06 | $-1.47 | 0.00 |
2020-06-30 | 56.43 | $-1.31 | 0.00 |
2020-03-31 | 50.03 | $-1.25 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $42.518B | $9.911B |
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $183.575B | 80.41 |
Thermo Fisher Scientific (TMO) | United States | $152.039B | 18.39 |
Edwards Lifesciences (EW) | United States | $44.083B | 28.90 |
IDEXX Laboratories (IDXX) | United States | $42.037B | 48.31 |
DexCom (DXCM) | United States | $32.149B | 49.69 |
IQVIA Holdings (IQV) | United States | $27.142B | 15.20 |
Mettler-Toledo (MTD) | United States | $24.013B | 28.56 |
STERIS (STE) | Ireland | $23.741B | 26.15 |
Waters (WAT) | United States | $20.370B | 28.74 |
SONOVA HOLDING (SONVY) | Switzerland | $18.723B | 0.00 |
Hologic (HOLX) | United States | $14.429B | 15.68 |
Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
Penumbra (PEN) | United States | $9.933B | 77.96 |
Masimo (MASI) | United States | $8.740B | 32.24 |
Globus Medical (GMED) | United States | $7.974B | 19.00 |
Glaukos (GKOS) | United States | $5.577B | 0.00 |
Teleflex (TFX) | United States | $5.300B | 8.75 |
TransMedics (TMDX) | United States | $4.833B | 105.06 |
Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
PROCEPT BioRobotics (PRCT) | United States | $3.355B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.495B | 14.86 |
Nihon Kohden (NHNKY) | Japan | $2.264B | 25.96 |
Veracyte (VCYT) | United States | $2.071B | 29.05 |
Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
Alphatec Holdings (ATEC) | United States | $1.617B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.383B | 0.00 |
Artivion (AORT) | United States | $1.206B | 113.00 |
Pulse Biosciences (PLSE) | United States | $1.061B | 0.00 |
OPKO Health (OPK) | United States | $1.055B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $0.945B | 5.02 |
Beta Bionics (BBNX) | United States | $0.828B | 0.00 |
SiBone (SIBN) | United States | $0.742B | 0.00 |
IRadimed (IRMD) | United States | $0.740B | 37.53 |
RxSight (RXST) | United States | $0.577B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
Delcath Systems (DCTH) | United States | $0.534B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.530B | 12.42 |
OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
AxoGen (AXGN) | United States | $0.444B | 0.00 |
AngioDynamics (ANGO) | United States | $0.433B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.431B | 0.00 |
NeuroPace (NPCE) | United States | $0.363B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.357B | 0.00 |
Semler Scientific (SMLR) | United States | $0.330B | 8.78 |
ClearPoint Neuro (CLPT) | United States | $0.323B | 0.00 |
908 Devices (MASS) | United States | $0.262B | 0.00 |
Neuronetics (STIM) | United States | $0.249B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.183B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.174B | 0.00 |
Inogen (INGN) | United States | $0.168B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
CVRx (CVRX) | United States | $0.153B | 0.00 |
LENSAR (LNSR) | United States | $0.147B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
Accuray (ARAY) | United States | $0.126B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.079B | 48.10 |
EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
InspireMD (NSPR) | United States | $0.071B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
Hyperfine (HYPR) | United States | $0.056B | 0.00 |
Spectral AI (MDAI) | United States | $0.050B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
Precision Optics (POCI) | United States | $0.037B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
DarioHealth (DRIO) | United States | $0.030B | 0.00 |
Envoy Medical (COCH) | United States | $0.029B | 0.00 |
NexGel (NXGL) | United States | $0.020B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.001B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.35 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |